A detailed history of Tang Capital Management LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Tang Capital Management LLC holds 400,000 shares of EDIT stock, worth $768,000. This represents 0.04% of its overall portfolio holdings.

Number of Shares
400,000
Holding current value
$768,000
% of portfolio
0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$1.2 - $3.76 $480,000 - $1.5 Million
400,000 New
400,000 $508,000
Q2 2023

Aug 14, 2023

BUY
$6.36 - $11.47 $1.27 Million - $2.29 Million
200,000 New
200,000 $1.65 Million

Others Institutions Holding EDIT

About Editas Medicine, Inc.


  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $132M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Tang Capital Management LLC Portfolio

Follow Tang Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tang Capital Management LLC with notifications on news.